E. Powell

发表

A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.

J. Cheville, V. Pankratz, T. Ebert, 2002, The Journal of urology.

Detecting expression of 5T4 in CTCs and tumor samples from NSCLC patients

Shibing Deng, Wenyan Zhong, H. Gerber, 2017, PloS one.

Concordant Loss of MTAP and p16/CDKN2A Expression in Gastroesophageal Carcinogenesis: Evidence of Homozygous Deletion in Esophageal Noninvasive Precursor Lesions and Therapeutic Implications

E. Montgomery, A. Maitra, M. Canto, 2005, The American journal of surgical pathology.

Pixelwise H-score: A novel digital image analysis-based metric to quantify membrane biomarker expression from immunohistochemistry images

S. Ram, Shibing Deng, Pamela M Whalen, 2021, bioRxiv.

First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody–Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors

D. Xuan, M. Maitland, A. Tolcher, 2021, Clinical Cancer Research.

Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome

J. Bienkowska, Shibing Deng, P. Rejto, 2020, Nature Communications.

PF-06647020 (PF-7020), an antibody-drug conjugate (ADC) targeting protein tyrosine kinase 7 (PTK7), in patients (pts) with advanced solid tumors: Results of a phase I dose escalation and expansion study.

D. Xuan, M. Maitland, A. Tolcher, 2018 .

Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer.

M. Socinski, G. Scagliotti, E. Smit, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase 1 study of PF-06647020, an antibody-drug conjugate (ADC) targeting protein tyrosine kinase 7 (PTK7), in patients with advanced solid tumors including platinum resistant ovarian cancer (OVCA)

D. Xuan, M. Maitland, A. Tolcher, 2016 .

Abstract PD2-08: Serial genomic profiling reveals molecular mechanisms of breast cancer resistance to palbociclib

J. Bienkowska, Shibing Deng, P. Rejto, 2022, Cancer Research.

Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer

J. Bienkowska, Shibing Deng, P. Rejto, 2023, Genome Medicine.

54 A strategy to quantitatively assess the accuracy and precision of multiplex immunofluorescence assays – application to Ultivue Insituplex® PD-L1, T-act and APC panels

E. Powell, S. Ram, 2021, Journal for ImmunoTherapy of Cancer.